Meta Platforms is the IBD Stock of the Day for Monday. Shares of the Facebook parent company have formed a flat base pattern after bouncing back last week from a slight earnings letdown. Please watch ...

A Relative Strength Rating upgrade for Chesapeake Utilities shows improving technical performance. Will it continue?

Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Bhubaneswar: Smruti Swarup Patra, known by his stage name ‘Nextion’, has emerged as the first runner-up in the ‘Ultimate ...

New research from ACG 2024 reveals that primary sclerosing cholangitis raises colorectal cancer risk even in patients without ...

Anticipation builds for Indias Best Dancer Season 4 finale with Arjun Kapoor and Tiger Shroff. Expect thrilling performances ...

Alcohol can worsen Crohn’s disease symptoms, but the impact varies from person to person. It may depend on what and how much ...